Bio-Rad Announces Mini-Protean Tetra Cell Users Website
News Aug 20, 2008
Bio-Rad Laboratories, Inc. has announced the introduction of www.mytetracell.com, a new online social networking site created for current and new Bio-Rad Mini-PROTEAN® system users to share and exchange ideas and information.
Once registered, the user can explore the many features of the site and earn points that may be redeemed for promotional items.
Designed to promote information sharing and networking amongst life scientists, mytetracell.com features include multiple forums where users can share ideas and thoughts, test their knowledge, explore and contribute to the photo gallery, take a product tour of the Mini-PROTEAN Tetra cell, visit the “Tetrastore” for promotional items and access regional promotions that are regularly updated.
“In our technology-driven research environment, the internet has become a valuable tool to connect, share, and disperse information. We are proud to launch mytetracell.com as an informational tool for protein research scientists around the world,” said Jeff Xu, product manager for Bio-Rad Laboratories.
Researchers Awarded $28M for Illuminating Druggable Genome NIH GrantsNews
Researchers receive grants as part of the NIH program focused on experimental and informatics approaches to characterize understudied proteins from three gene families: ion channels, G protein-coupled receptors (GPCRs), and protein kinases.READ MORE
No Country for Old GenesNews
Our modern world is radically different from the one we evolved in, and that creates a mismatch between the environment our genes were evolved to face, and the world those genes now encounter. A new review looks at how certain genes that benefited humans in our genetic past now predispose us to disease in old age.READ MORE
CRISPR Editing Stops HIV Virus in Infected CellsNews
Human immunodeficiency virus-1 (HIV-1) infection is a chronic disease affecting more than 35 million people worldwide. The infection can be controlled by antiretroviral therapy (ART), but there is still no complete cure. Now, a new study targeting the regulatory genes of the virus using CRISPR/Cas9 has helped block the production of the virus by infected cells.READ MORE